Literature DB >> 30305952

Atrial septal defect (ASD) device trans-catheter closure: limitations.

Alessia Faccini1, Gianfranco Butera1.   

Abstract

Transcatheter closure is a widespread technique used to treat secundum atrial septal defects (ASDs). When compared to surgery, it provides a less invasive approach with quicker recovery and reduced physical and psychological impact. Nowadays, almost 85-90% of all secundum ASD can be closed by using a transcatheter approach. However, several limitations may have a significant impact on the feasibility and success of percutaneous ASD closure. Limitations can be grouped as: (I) anatomical; (II) device-related; (III) associated defects and natural history associated issues; (IV) physiological; (V) complications. Physician should be aware of potential limits of percutaneous ASD closure.

Entities:  

Keywords:  Heart septal defect; atrial; interventional cardiology; septal occlude device

Year:  2018        PMID: 30305952      PMCID: PMC6174146          DOI: 10.21037/jtd.2018.07.128

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  58 in total

Review 1.  Treatment options for the closure of secundum atrial septal defects: A systematic review and meta-analysis.

Authors:  Pedro A Villablanca; David A Briston; Josep Rodés-Cabau; David F Briceno; Gaurav Rao; Mohammed Aljoudi; Aman M Shah; Divyanshu Mohananey; Tanush Gupta; Mohammed Makkiya; Harish Ramakrishna; Mario J Garcia; Robert H Pass; Giles Peek; Ali N Zaidi
Journal:  Int J Cardiol       Date:  2017-03-24       Impact factor: 4.164

2.  Transcatheter closure of secundum atrial septal defects: has fear of device erosion altered outcomes?

Authors:  Bryan Mitchelson; Clare O'Donnell; Peter Ruygrok; John Wright; John Stirling; Nigel Wilson
Journal:  Cardiol Young       Date:  2017-01-12       Impact factor: 1.093

3.  Feasibility of Repairing Defects Followed by Treatment with Pulmonary Hypertension-specific Drugs (Repair and Treat) in Patients with Pulmonary Hypertension Associated with Atrial Septal Defect: Study Protocol for Interventional Trial.

Authors:  Satoshi Akagi; Kazufumi Nakamura; Teiji Akagi; Koji Nakagawa; Yoichi Takaya; Toshihiro Sarashina; Kentaro Ejiri; Hiroshi Ito
Journal:  Acta Med Okayama       Date:  2016-10       Impact factor: 0.892

4.  Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience.

Authors:  J Masura; P Gavora; A Formanek; Z M Hijazi
Journal:  Cathet Cardiovasc Diagn       Date:  1997-12

5.  Transcatheter closure of large atrial septal defects: feasibility and safety in a large adult and pediatric population.

Authors:  Alban-Elouen Baruteau; Jérôme Petit; Virginie Lambert; Marielle Gouton; Dominique Piot; Philippe Brenot; Claude-Yves Angel; Lucile Houyel; Emmanuel Le Bret; Régine Roussin; Mohamedou Ly; André Capderou; Emre Belli
Journal:  Circ Cardiovasc Interv       Date:  2014-11-25       Impact factor: 6.546

6.  Masked left ventricular restriction in elderly patients with atrial septal defects: a contraindication for closure?

Authors:  P Ewert; F Berger; N Nagdyman; O Kretschmar; S Dittrich; H Abdul-Khaliq; P Lange
Journal:  Catheter Cardiovasc Interv       Date:  2001-02       Impact factor: 2.692

Review 7.  Fenestrated Transcatheter ASD Closure in Adults with Diastolic Dysfunction and/or Pulmonary Hypertension: Case Series and Review of the Literature.

Authors:  Ayman Abdelkarim; Daniel S Levi; Bao Tran; Joanna Ghobrial; Jamil Aboulhosn
Journal:  Congenit Heart Dis       Date:  2016-04-29       Impact factor: 2.007

8.  The influence of deficient retro-aortic rim on technical success and early adverse events following device closure of secundum atrial septal defects: An Analysis of the IMPACT Registry®.

Authors:  Michael L O'Byrne; Matthew J Gillespie; Kevin F Kennedy; Yoav Dori; Jonathan J Rome; Andrew C Glatz
Journal:  Catheter Cardiovasc Interv       Date:  2016-05-18       Impact factor: 2.692

9.  Closure of Secundum Atrial Septal Defects by Using the Occlutech Occluder Devices in More Than 1300 Patients: The IRFACODE Project: A Retrospective Case Series.

Authors:  Nikolaus A Haas; Dagmar B Soetemann; Ismail Ates; Osman Baspinar; Igor Ditkivskyy; Christopher Duke; Francois Godart; Avraham Lorber; Edmundo Oliveira; Eustaquio Onorato; Feyza Pac; Worakan Promphan; Frank-Thomas Riede; Supaporn Roymanee; Robert Sabiniewicz; Suhair Omar Shebani; Horst Sievert; Do Tin; Christoph M Happel
Journal:  Catheter Cardiovasc Interv       Date:  2016-03-31       Impact factor: 2.692

Review 10.  Transcatheter closure of secundum atrial septal defects.

Authors:  Suhaib Kazmouz; Damien Kenny; Qi-Ling Cao; Clifford J Kavinsky; Ziyad M Hijazi
Journal:  J Invasive Cardiol       Date:  2013-05       Impact factor: 2.022

View more
  5 in total

Review 1.  Anaesthesia for the paediatric patient in the cardiac catheterisation laboratory.

Authors:  N Tierney; D Kenny; D Greaney
Journal:  BJA Educ       Date:  2021-12-13

2.  Clinical evaluation of percutaneous and intra-operative device closure of atrial septal defects under transesophageal echocardiographic guidance: one center experience and mid-term follow-up.

Authors:  Peng Zhu; Haifeng Qiang; Fei Liu; Peng Xie; Shaoyi Zheng; Yong Sun
Journal:  J Cardiothorac Surg       Date:  2020-01-14       Impact factor: 1.637

3.  Completed atrioventricular block induced by atrial septal defect occluder unfolding: A case report.

Authors:  Chuan He; Yang Zhou; Si-Si Tang; Li-Hong Luo; Kun Feng
Journal:  World J Clin Cases       Date:  2020-11-26       Impact factor: 1.337

4.  Preliminary Experience With the New Amplatzer™ Trevisio™ Delivery System in Transcatheter Atrial Septal Defect Closures in Children.

Authors:  Raymond N Haddad; Diala Khraiche; Damien Bonnet; Mathilde Meot; Sophie Malekzadeh-Milani
Journal:  Front Pediatr       Date:  2021-03-11       Impact factor: 3.418

5.  Transcatheter closure of secundum atrial septal defect using Cocoon septal occluder: immediate and long-term results.

Authors:  Santosh Kumar Sinha; Mahmodullah M Razi; Najeeb Ullah Sofi; Manoj Kumar Rohit; Umeshwar Pandey; Awadhesh Kumar Sharma; Mohit Sachan; Puneet Aggarwal; Mukesh Jha; Praveen Shukla; Ramesh Thakur; Vinay Krishna; Rakesh Kumar Verma
Journal:  Egypt Heart J       Date:  2022-08-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.